Bruker EBITDA Margin 2010-2023 | BRKR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bruker (BRKR) over the last 10 years. The current EBITDA margin for Bruker as of December 31, 2023 is .
| Bruker EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$2.96B |
$0.55B |
18.62% |
| 2023-09-30 |
$2.82B |
$0.57B |
20.12% |
| 2023-06-30 |
$2.71B |
$0.57B |
20.93% |
| 2023-03-31 |
$2.62B |
$0.55B |
21.07% |
| 2022-12-31 |
$2.53B |
$0.52B |
20.63% |
| 2022-09-30 |
$2.51B |
$0.51B |
20.52% |
| 2022-06-30 |
$2.48B |
$0.50B |
20.08% |
| 2022-03-31 |
$2.46B |
$0.51B |
20.67% |
| 2021-12-31 |
$2.42B |
$0.50B |
20.72% |
| 2021-09-30 |
$2.36B |
$0.49B |
20.65% |
| 2021-06-30 |
$2.27B |
$0.46B |
20.09% |
| 2021-03-31 |
$2.12B |
$0.41B |
19.11% |
| 2020-12-31 |
$1.99B |
$0.33B |
16.55% |
| 2020-09-30 |
$1.96B |
$0.33B |
16.84% |
| 2020-06-30 |
$1.97B |
$0.34B |
17.01% |
| 2020-03-31 |
$2.04B |
$0.35B |
17.25% |
| 2019-12-31 |
$2.07B |
$0.38B |
18.19% |
| 2019-09-30 |
$2.03B |
$0.36B |
17.97% |
| 2019-06-30 |
$1.97B |
$0.34B |
17.34% |
| 2019-03-31 |
$1.93B |
$0.33B |
17.34% |
| 2018-12-31 |
$1.90B |
$0.33B |
17.24% |
| 2018-09-30 |
$1.87B |
$0.32B |
16.81% |
| 2018-06-30 |
$1.84B |
$0.30B |
16.17% |
| 2018-03-31 |
$1.81B |
$0.28B |
15.66% |
| 2017-12-31 |
$1.77B |
$0.28B |
16.02% |
| 2017-09-30 |
$1.71B |
$0.27B |
15.65% |
| 2017-06-30 |
$1.66B |
$0.26B |
15.56% |
| 2017-03-31 |
$1.62B |
$0.24B |
14.93% |
| 2016-12-31 |
$1.61B |
$0.24B |
14.65% |
| 2016-09-30 |
$1.62B |
$0.23B |
13.90% |
| 2016-06-30 |
$1.62B |
$0.21B |
12.77% |
| 2016-03-31 |
$1.65B |
$0.22B |
13.25% |
| 2015-12-31 |
$1.62B |
$0.20B |
12.32% |
| 2015-09-30 |
$1.65B |
$0.17B |
10.46% |
| 2015-06-30 |
$1.68B |
$0.15B |
9.18% |
| 2015-03-31 |
$1.74B |
$0.16B |
9.14% |
| 2014-12-31 |
$1.81B |
$0.17B |
9.18% |
| 2014-09-30 |
$1.85B |
$0.19B |
10.04% |
| 2014-06-30 |
$1.87B |
$0.21B |
11.22% |
| 2014-03-31 |
$1.87B |
$0.22B |
11.71% |
| 2013-12-31 |
$1.84B |
$0.21B |
11.42% |
| 2013-09-30 |
$1.80B |
$0.19B |
10.48% |
| 2013-06-30 |
$1.81B |
$0.22B |
11.91% |
| 2013-03-31 |
$1.78B |
$0.19B |
10.91% |
| 2012-12-31 |
$1.79B |
$0.22B |
12.00% |
| 2012-09-30 |
$1.75B |
$0.23B |
12.91% |
| 2012-06-30 |
$1.72B |
$0.20B |
11.80% |
| 2012-03-31 |
$1.70B |
$0.22B |
12.88% |
| 2011-12-31 |
$1.65B |
$0.21B |
12.66% |
| 2011-09-30 |
$1.59B |
$0.21B |
12.88% |
| 2011-06-30 |
$1.48B |
$0.20B |
13.68% |
| 2011-03-31 |
$1.38B |
$0.20B |
14.09% |
| 2010-12-31 |
$1.31B |
$0.19B |
14.71% |
| 2010-09-30 |
$1.26B |
$0.22B |
17.13% |
| 2010-06-30 |
$1.21B |
$0.20B |
16.45% |
| 2010-03-31 |
$1.16B |
$0.18B |
15.58% |
| 2009-12-31 |
$1.12B |
$0.17B |
14.98% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$11.768B |
$2.965B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
